San Francisco, USA – June 27, 2023 – Swissnex in San Francisco selected six promising Swiss startups to explore and conquer the US market during a two week bootcamp. This bootcamp is part of the internationalization camps proposed by Innosuisse across the world to Swiss start-ups participating in its coaching, and the 14th edition of the bootcamp in San Francisco. Past participants include the well known doodle, Mindmaze, faceshift, Nexthink, and Ava Women. Swissnex in San Francisco has over two decades of experience in connecting Switzerland to the Western United States.
From June 19 to June 30, 2023, six Swiss startups traveled to San Francisco to explore and conquer the US market with their temporary base at Pier 17, home of Swissnex in San Francisco. Powered by Innosuisse, the Bootcamps provide Swiss founders with the tools, knowledge, and connections to establish their presence in the United States. This iteration of the 2-week bootcamp was tailored to Swiss startups in the Health, Food, & Wellbeing space.
This cohort consisted of the following startups:
- Cellestia BioTech AG
- Magnes AG
- MindMetrix AG
- Rea Diagnostics
- SURI BioTech
Adopting the San Francisco Mindset as a Key to Success
Swissnex in San Francisco provided training on how to pitch the American way, how to respond to challenging questions from local investors, as well as legal advice, expert sessions on establishing a digital marketing presence in the US, as well as fireside chats with local industry experts and further connected the startups with Bay Area mentors and coaches. One of the bootcamp highlights was the pitch night, where each member of the cohort channeled their newfound knowledge into a short, on-stage pitch, judged by renowned Bay Area investors, Maire P. Walsh, Co-Founder and CEO at Belayer, Santhi Analytis, Advisor and Angel Investor, and Sunil Maulik, Managing Partner at SunilM.
ReaDiagnostics was announced the winner of the pitch night, after delivering a smooth pitch and answering the jury questions with confidence. CEO Loulia Kassem is well aware of the difference between pitching in Switzerland and pitching in San Francisco: “As a Swiss start-up, we’re used to pitching with precision. However, engaging with the American start-up scene introduces a unique dynamism to this process. This experience encourages us to constantly evolve our approach, blending Swiss precision with American energy to communicate our vision effectively.”
Julia Bislin, Entrepreneurship Program Manager at Swissnex in San Francisco, knows that these bootcamps can be tremendous door openers to dedicated entrepreneurs: “I have witnessed firsthand the value that Swiss startups bring to the US market. Swiss founders possess a unique combination of expertise, precision, and a relentless pursuit of quality. If you mix that with American confidence, optimism, and perseverance, you have a recipe for success.”
The next Bootcamp takes place in September and is open to startups of all industries. Bootcamps in 2024 will be focused on startups in the fields of Health, Trust in AI and ClimateTech. Registration opens soon. For more information about the bootcamps at Swissnex in San Francisco, please visit our startup page.
Startup Pitch Night, June 2023
About the startups
Zoundream uses cutting edge developments in sound recognition, to the specific field of baby cries. Their technology can not only translate cries in real time (e.g. hungry, sleepy), but most importantly, identify potential pathologies and development disorders – improving the well-being of families and babies, all around the world. Roberto is Zoundream’s CEO, and one of the co-founders. Master in Engineering, with an Executive MBA at INSEAD. Past experiences in management consulting, large corporates, and some more. Most important, he has two wonderful daughters: Sofia (5) and Bianca (1).
About Rea Diagnostics
Rea DiagnosticsErick Garcia Cordero (CTO) and Loulia Kassem (CEO)
Rea Diagnostics is an innovative startup transforming women’s healthcare. Their first product helps pregnant women predict a risk of a preterm birth, bringing accessibility to prenatal care. They are also designing a game-changing ‘Smart Pad’ to analyze menstrual blood and vaginal discharge, aiming to optimize disease management and fuel new drug discoveries. Together, Erick Garcia Cordero (CTO) and Loulia Kassem (CEO) are part of the Swissnex in San Francisco bootcamp cohort, representing Rea Diagnostics.
About Cellestia Biotech
Cellestia BiotechRaj Lehal
Cellestia Biotech is a clinical-stage company developing a revolutionary treatment for autoimmune diseases and genetically defined human cancers. Their lead drug candidate is advancing in clinical trials and pre-clinical candidates are ready for IND enabling studies. Cellestia’s pipeline holds the potential to introduce a paradigm shift in the management of auto immune diseases and cancers. Raj Lehal, CEO and co-founder of Cellestia Biotech AG, is driven by an ambitious goal of bringing life saving medicines to patients.
About MindMetrix AG
MindMetrix AGLara Ming & Marc Bächinger
MindMetrix AG is an ETH Zurich spin-off based in Zurich, Switzerland, with the mission to make mental training measurable and trackable. It is the objective of their product, myflow, to provide competitive athletes with scientifically validated technology, which will help them train and improve their mental strength and well-being.
About Magnes AG
Magnes AGDr. Olgac Ergeneman
Magnes has developed a disruptive real-life-monitoring solution to analyze the walking patterns of patients with neurological disorders. It is the only solution to give direct vibrotactile biofeedback to patients. Using smart sensors embedded in sneaker-like shoes Magnes collects data while the patient is walking or doing daily activities. Their AI processes the data to generate automatic reports and provide the patient with direct feedback on their gait or warn/prevent situations like falling.
CEO Dr. Olgac Ergeneman is an Electrical Engineer with a PhD in medical robotics from ETH Zurich wiith over 10 years of experience in medical robotics, sensors, and tech transfer. COO Dr. George Chatzipirpiridis is a Mechanical Engineer with a PhD in medical robotics from ETH Zurich with over 10 years of experience in product development, mechanical design, Industrialization.
About SURI BioTech
SURI BioTechDr. Vanesa Rocha Martin
SURI BioTech develops precision probiotics for the first 1000 days of life and apply a novel approach to developing precision probiotics. The natural strains included in their products are rationally selected for their ability to be active in infant gut conditions. Dr. Vanesa Rocha Martin is the CEO of SURI BioTech, leading the way in groundbreaking research and technologies focused on infant gut microbiota. Her pioneering Ph.D. studies have laid the scientific groundwork for SURI’s innovative advancements in healthcare.